Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 236,198 $ 0 $ 469,396   $ (233,237)
Beginning Balance at Dec. 31, 2023       $ 39  
Beginning balance, Shares at Dec. 31, 2023   47,823,232      
Issuance of common stock, net of issuance costs, value 10,876 $ 1 10,875    
Issuance of common stock, net of issuance costs, shares   1,483,070      
Issuance of common stock in connection with exercise of stock options, value 1,430   1,430    
Issuance of common stock in connection with exercise of stock options, Shares   210,695      
Issuance of common stock under employee stock purchase plan, value 269   269    
Issuance of common stock under employee stock purchase plan, Shares   58,056      
Issuance of common stock upon exercise of pre-funded warrants, Shares   1,168,048      
Net unrealized losses on available-for-sale securities, value (39)     (39)  
Stock-based compensation, value 19,465   19,465    
Net Income (Loss) (115,864)       (115,864)
Ending balance at Dec. 31, 2024 $ 152,335 $ 1 501,435 0 (349,101)
Ending balance, Shares at Dec. 31, 2024 50,743,101 50,743,101      
Issuance of common stock, warrants and pre-funded warrants, net of issuance costs, share   39,200,000      
Issuance of common stock, warrants and pre-funded warrants, net of issuance costs, value $ 93,558   93,558    
Issuance of common stock from ATM offering, net of sales agent commission and fees, share   5,545,041      
Issuance of common stock from ATM offering, net of sales agent commission and fees, Value 12,745   12,745    
Issuance of common stock in connection with exercise of stock options, value 14   14    
Issuance of common stock in connection with exercise of stock options, Shares   13,334      
Issuance of common stock under employee stock purchase plan, value 291   291    
Issuance of common stock under employee stock purchase plan, Shares   177,876      
Issuance of common stock upon exercise of pre-funded warrants, Shares   4,799,971      
Net unrealized losses on available-for-sale securities, value 25     25  
Stock-based compensation, value 20,939   20,939    
Net Income (Loss) (167,856)       (167,856)
Ending balance at Dec. 31, 2025 $ 112,051 $ 1 $ 628,982   $ (516,957)
Ending Balance at Dec. 31, 2025       $ 25  
Ending balance, Shares at Dec. 31, 2025 100,479,323 100,479,323